Consun Pharma (01681) announced that Li Yikai has been appointed as an independent non-executive director, the chairman of nomination committee and a member of the audit committee. It will take effect on June 21, 2024.
Consun Pharma (01681) announced that Li Yikai has been appointed as an independent non-executive director, the chairman of nomination committee and a member of the audit committee. It will take effect on June 21, 2024.
Starting from the same day, Zhang Lihua no longer serves as a member of the audit committee, and Feng Zhongshi no longer serves as the chairman and member of the nomination committee.